Nick Thomas-Symonds MP: speeches

Speeches

• 5 Jun 2025 · Infected Blood Compensation Scheme · Hansard source

  More

  My hon. Friend is absolutely right about the need to reach out to all communities and ensure that every single victim secures justice. I assure her that that is absolutely what the Government are committed to doing.

• 5 Jun 2025 · Infected Blood Compensation Scheme · Hansard source

  More

  Payments to infected people started at the end of last year. The Government expect payments to affected people to start by the end of this year. The Infected Blood Compensation Authority, which is independent of Government, publishes updated figures fortnightly. As of 3 June, it has contacted 1,360 people to begin a claim and made offers to 324 people, totalling £253 million. There is much further to go, but progress is being made in delivering justice to the victims of this devastating scandal.

• 14 May 2025 · Infected Blood Inquiry: Government Response · Hansard source

  More

  I have met Clive Smith and I pay tribute to the campaigning work that he has done over many years. On updating, I entirely agree with the hon. Gentleman that it is important—that is why IBCA publishes regular newsletters with updates on the statistics—but he also identifies a statistic that should give us all pause for thought, which is that a victim of this scandal is still dying every few days. That shows the impetus and the imperative to speed these compensation payments up, and that is absolutely what I am committed to do.

• 14 May 2025 · Infected Blood Inquiry: Government Response · Hansard source

  More

  Again, I am sure that the thoughts of the whole House will be with the hon. Gentleman’s constituent, given the terrible experience that she has clearly had. With regard to the category of victims he is talking about—unregistered, living, infected people—he is absolutely right to raise their position. The objective of this compensation scheme is to ensure that every victim, whatever their circumstances, receives the compensation they are due, and that obviously includes his constituent.

• 14 May 2025 · Infected Blood Inquiry: Government Response · Hansard source

  More

  To the right hon. Gentleman’s point about potential criminal sanctions, I have always said that I stand ready to provide whatever evidence might be requested of the Cabinet Office and across Government to any investigation. To his point about a duty of candour, Sir Brian Langstaff said that there was not an explicit conspiracy; rather, there was a culture of institutional defensiveness whereby individual public servants put personal and institutional reputation above the public good. As I said earlier in response to the hon. Member for Richmond Park (Sarah Olney), the Government will bring forward legislation on a duty of candour. However, it is not just about legislation, landmark though it is; it is about leadership across public service to change culture, which will be important in the years ahead.

• 14 May 2025 · Infected Blood Inquiry: Government Response · Hansard source

  More

  With permission, Madam Deputy Speaker, I will make a statement on the Government’s work to respond to the recommendations made in the infected blood inquiry’s 20 May 2024 report. I am grateful for the opportunity to update the House on this work. On 20 May 2024, the then Prime Minister issued an apology on behalf of the state for the devastating impact that the use of infected blood and infected blood products has had on countless lives. That was echoed by the current Prime Minister, who was then on the Opposition Front Bench. I once again reiterate that apology wholeheartedly. No Member of this House will be in any doubt of the harm resulting from the infected blood scandal. This Government are firm that we must listen to the infected blood community and the inquiry and make tangible changes to the way that our institutions conduct themselves. As the inquiry’s report made clear, however, an apology is meaningful only if it is accompanied by action, and I am here today to set out the actions we are taking to respond to the inquiry’s recommendations. Last week, the inquiry held further hearings on the timeliness and adequacy of the Government’s response on compensation. I attended to give evidence, along with members of the community who have been impacted by this scandal; I encourage all Members to listen to the incredibly moving testimonies of those impacted. The inquiry has set out its intention to publish a further report, and the Government remain committed to co-operating with the inquiry and acting on its recommendations. On 17 December 2024, the Government published our initial response to the inquiry’s recommendations. I laid before the House an accompanying written statement, in which I committed to come before the House with a comprehensive update on our response to each of the inquiry’s recommendations within a year of the inquiry’s report. This statement fulfils that commitment. I am grateful for the engagement of all Members across the House, and am pleased to have the opportunity to discuss the Government’s progress today. Once again, I thank Sir Brian Langstaff and his team for their work. The recommendations he made are wide-ranging, well considered and necessarily detailed. The Government have worked closely with the devolved Governments to make progress on the implementation of the recommendations, which we hope will lead to meaningful change. I am grateful to my ministerial colleagues for their co-operation, and in particular the Under-Secretary of State for Public Health and Prevention, my hon. Friend the Member for West Lancashire (Ashley Dalton), for her leadership on the recommendations for which her Department is responsible. I also thank Health Ministers in the devolved Governments: the Minister for Public Health and Women’s Health in Scotland, Jenni Minto; the Cabinet Secretary for Health and Social Care in Wales, Jeremy Miles; and the Minister of Health in Northern Ireland, Mike Nesbitt. Their engagement has been invaluable in ensuring that our approach is as unified as possible across the whole United Kingdom. The Government will continue to engage closely with the devolved Governments on issues such as support for advocacy charities and implementation by the national health service. I recognise that for many in the community, the Government’s actions come after decades have passed. There is nothing that can put right the damage done by inaction on the part of multiple previous Governments, and it is not my intention for this statement to diminish that. My priority now is focusing on delivering meaningful change to ensure that the scandal of infected blood, among many other scandals, is never allowed to happen again. I turn now to the recommendations. Alongside this statement, I have published an accompanying paper on gov.uk setting out in detail the Government’s response to each of the recommendations, and I will place a copy in the Libraries of the Houses. Equally, I am firm on the importance of these recommendations to the infected blood community, and I am writing today to community representatives to inform them of the publication of the Government’s response. The UK and devolved Governments have accepted the inquiry’s recommendations either in full or in principle, and implementation is under way across Government, arm’s length bodies and healthcare settings. Where recommendations are accepted in principle, we have sought to explain the rationale for doing so, balancing agreement with the spirit of the recommendations and their implementation. Some are subject to future spending decisions by the Department of Health and Social Care. I have noted the recommendations that have, quite rightly, drawn attention from across this House in previous debates, so I will take a moment to touch on those today. I turn first to the recommendation on compensation. I am grateful to those who have attended previous debates on this matter in the House; indeed, many are present today. The Infected Blood Compensation Authority delivered on the Government’s commitment to provide the first full compensation payments by the end of last year. IBCA publishes its data on compensation on a monthly basis; as of 6 May, payments totalling more than £96 million have been made. IBCA continues to scale up its operations to deliver compensation as quickly as possible and has confirmed plans to contact an average of 100 people every week to begin their claims. I am pleased to announce today that the interim chair, Sir Robert Francis KC, who developed vital work to inform the design of the compensation scheme and has overseen its delivery to this point, will continue in his role for a further 18 months. Another recommendation of particular interest to right hon. and hon. Members is recommendation 10, relating to funding for charities providing patient advocacy services. I am pleased that last week, the Under-Secretary of State for Health and Social Care, my hon. Friend the Member for West Lancashire (Ashley Dalton), wrote to the charities confirming that £500,000 of funding has been made available for this financial year to ensure that the vital patient advocacy work they do for the infected blood community is sustained. Officials are now meeting the charities to begin the grant process to finalise the awards. The Government recognise the importance of recommendation 5 on ending the defensive culture in the civil service. It is imperative we get this right so that the public can put their trust in institutions that have let down not just the infected blood community, but victims of other scandals that have taken place over decades. The Prime Minister has committed to legislation on a duty of candour, which he has confirmed will apply to public authorities and public servants, and include criminal sanctions. We are consulting on the issue and working to draft the best, most effective version of a Hillsborough law as part of our wider efforts to create a politics of public service. The inquiry’s final recommendation relates to giving effect to the recommendations it has made. I am only too aware of the strength of feeling here and the need to ensure that the infected blood scandal does not fade from the public consciousness. A lot more needs to be done, and, as I made clear to the inquiry in my evidence last week, I am open to considering how we can improve the Government’s actions to ensure that we deliver justice for the victims of this devastating scandal. As progress continues to be made, my colleagues and I will report on the recommendations for which we are responsible. We are committed to transparency and accountability, and will be publishing the Government’s progress via a publicly accessible dashboard in due course, which will be regularly updated as progress is made. The victims of this scandal have suffered immeasurably. I pay tribute once again to the infected blood community for their courage, perseverance and determination to demand justice for the wrongs that have been done to them. I hope that this update provides them with some reassurance that we are learning from and acting on the mistakes of the past, and that where there is more to do, this Government will do it. I commend this statement to the House.

• 24 Apr 2025 · Infected Blood Compensation Scheme · Hansard source

  More

  The infected blood scandal is the worst medical scandal in the history of our NHS, and the infected blood compensation scheme was set up to provide some small measure of justice to victims and their families. We have set aside £11.8 billion for victims, and since the scheme became law on 31 March, the Infected Blood Compensation Authority has the powers it needs to press ahead and make payments to those eligible for compensation. The compensation payments began last December, and 69 people have accepted their offers, totalling more than £71 million.

• 24 Mar 2025 · Draft Infected Blood Compensation Scheme Regulations 2025 · Hansard source

  More

  I beg to move, That the Committee has considered the draft Infected Blood Compensation Scheme Regulations 2025. It is a pleasure to serve under your chairmanship, Sir Edward. Let me first address the reason we are here today. The infected blood scandal was a profound failure of the state. It is hard to conceive the scale of the damage done and the incredible suffering of all those impacted. It is important that those people remain at the forefront of our minds. It is for them that we must do everything in our power to rectify this injustice, restore trust in the state and demonstrate that we will not allow such failures to happen again. This scandal was allowed to go unaddressed for generations, and the onus is on us to rebuild relationships and support those impacted as they progress through the next chapter of their journey. That is why in the autumn Budget, we set aside £11.8 billion to compensate people who are infected and affected by the infected blood scandal. It is, rightly, one of the largest compensation schemes in our country’s history. The compensation scheme was first established in August last year by regulations approved by the House. The scheme is a tariff-based compensation scheme that provides compensation under both a core and a supplementary route. Under the Infected Blood Compensation Scheme Regulations 2024, the Infected Blood Compensation Authority, or IBCA, has already made progress in paying infected people. As of 14 March, 255 people have been invited to start their compensation claim and 40 people have accepted their offers, totalling over £44 million. We recognise the scale of what needs to be done, and the Cabinet Office continues to work closely with IBCA to ensure that it works as quickly as possible to deliver compensation to people for whom it is long overdue. The draft regulations will consolidate the 2024 regulations and establish the compensation scheme in full, including for people who are affected: those loved ones of people who are infected, defined in the draft regulations as partners, parents, children, siblings and, in some instances, carers. The draft regulations will allow IBCA to begin making payments to people who are affected by the end of this year. The draft regulations will also establish the supplementary route, for exceptional cases in which compensation under the core route was not considered sufficient. The supplementary awards for infected people include an additional autonomy award, where someone was subjected to unethical research; a severe health condition award for financial loss and care, where someone suffered from a specific rare health condition that is likely to result in greater care needs or impact an infected person’s ability to work; and an exceptional loss award for financial loss and care, where someone can evidence additional financial loss, most likely as a result of being a higher earner or having higher care costs due to their infection. There is also a supplementary financial loss award for affected people. This will provide compensation where an affected person was financially dependent on an infected person at the time of their death and that dependency has not already been recognised through the core route. The supplementary route has a higher evidential requirement; people who are claiming will need to demonstrate that their circumstances necessitate a higher compensation award. Importantly, the draft regulations will also allow for people to return to the scheme should their condition worsen as a result of their infection, and for people to claim multiple awards in the devastating circumstances that they are both infected and affected, or affected multiple times over. I should acknowledge that the draft regulations also amend a small mathematical error that was present in the 2024 regulations. I apologise for this, and reassure the Committee that anyone affected by the issue will receive all the compensation they are due, and resolving the issue should not cause any delays in the roll-out of compensation. The error is a result of the mathematical formula used to calculate some people’s financial loss and care award in the 2024 regulations. To be clear, that means that some people who have been made an offer were offered slightly less than was intended. It will impact only a relatively small number of around 50 people who have received their offer of compensation from IBCA, and the discrepancy represents less than 1% of the claim amount. However, it is important that I draw this to the attention of Members. Once the problem was identified, we worked quickly to identify a solution to ensure no one was negatively impacted. IBCA has reached out to claimants today to inform them of the error. In addition to IBCA ensuring that everyone receives the correct amount of compensation, the people who were impacted by this will also receive a small ex gratia payment. I want to reassure Members that steps were taken quickly and the draft regulations have been reviewed thoroughly to ensure that the error has been properly addressed. I also highlight that a small amendment was made to today’s draft statutory instrument after it was laid to correct a very minor typographical mistake. Just to reassure Members, I note that the sub-paragraphs were (a) (b) (b) instead of (a) (b) (c), and there was an unnecessary comma. I reassure everyone that those errors have been corrected. I recently visited the IBCA team, led by Sir Robert Francis, and I know how determined they are for compensation to be paid out to victims as soon as possible. Nothing can ever undo the decades of injustice, pain and suffering, but the draft regulations are another step towards providing full and fair compensation to the people impacted by the infected blood scandal, who have already waited too long for justice. We, as a Government, and more widely as a party and as parliamentarians, should not rest until we see this delivered. We will work closely with IBCA to ensure that it prioritises providing payments quickly, efficiently and in a way that puts the people it is delivering for at the heart of its work. I look forward to hearing Members’ contributions.

• 24 Mar 2025 · Draft Infected Blood Compensation Scheme Regulations 2025 · Hansard source

  More

  The right hon. Gentleman has particular insight into the workings of the Cabinet Office. Like everyone in the room, he and I are restless for progress. We want these payments out of the door as soon as possible. The shadow Minister raised the issue of HIV, on the one hand, and hepatitis B and C, on the other. In terms of our tariff rates for hepatitis C, the impact of a hepatitis infection can obviously range from very mild to very severe, through to liver failure and death, as a direct result of the infection. The expert group—appointed by the right hon. Member for Salisbury—provided the Government with clinical advice on the distinctions between those impacts. That meant that we could set severity bands for hepatitis based on clear clinical markers. Therefore, where someone’s experience of hepatitis—whether historical or now—has been more severe, they will get more compensation. The expert group also recommended a single severity band for those infected with HIV. Sadly, most people infected with HIV due to infected blood have already died, and in most cases the death was as a result of that HIV infection. Those who survived will continue to be severely impacted by their infection. The view of the expert group, which the Government accepted, is that it is disproportionately complex to break down the HIV category into different severity bands. That is why there is a distinction in the bands. The shadow Minister rightly asked about affected estates. As he indicated, the Government are following Sir Brian Langstaff’s recommendation about how widely we draw the circle. Where an affected estate will have a claim is where there is a claim on a debt. What that means is that an offer was accepted while the affected person was alive. If there has been the offer and the acceptance, then the affected estate has a claim on the debt. We think that that is a reasonable place to draw the line, and it is in line with Sir Brian Langstaff’s recommendation. I am grateful for both contributions to the debate. There is huge importance to getting this right. It is about achieving fair and comprehensive compensation that is simple enough to deliver quickly without diminishing the individual harm that people have faced. That is the purpose of a tariff-based scheme: it is to get that balance right between swiftness of delivery and not diminishing individual harm. As the shadow Minister will know, if we look at an infected person, there is the injury award, the social impact award, the autonomy award, the financial loss award and the care award, and indeed the core route and the supplementary route. It is a scheme that is trying to strike that balance. No one is suggesting that this is a straightforward task, but if we look at the recommendations of the infected blood inquiry, at the work of Sir Robert Francis, the advice of the infected blood inquiry response expert group that was led so well by Sir Jonathan Montgomery— appointed by the right hon. Member for Salisbury—they have all made a significant contribution to where we are today. No amount of compensation will make up for the pain and suffering that the victims have faced, and the Government recognise that. Now, however, we need to focus on supporting the Infected Blood Compensation Authority, so I hope we get support for the draft regulations in a few moments; they will enable IBCA to provide that compensation swiftly and compassionately. I welcome and thank all Members who are interested in this topic. I appreciate the cross-party work on seeking justice, but I also say to all Members present—just as the right hon. Member for Salisbury did—that the door is open for them to raise individual cases and issues with me. Members should please raise them with the Cabinet Office, and I will do my best to ensure that they get a swift response. I hope all colleagues will join me in supporting the draft regulations, and I commend them to the Committee. Question put and agreed to . Resolved , That the Committee has considered the draft Infected Blood Compensation Scheme Regulations 2025.

• 13 Feb 2025 · Infected Blood Compensation Scheme · Hansard source

  More

  On the right hon. Gentleman’s point about tariffs, they have been set out and published. There are then assessments to be made about severity within the tariff bands. There is also, as I have indicated, the supplementary route for more complex cases. I cannot give him a single figure across these cases as they obviously vary, but the House will gradually see the overall amount being published by IBCA. On the right hon. Gentleman’s second point, a victim making an application to the IBCA will be given a particular claim manager—I met the first claim managers only in recent weeks—to speak to and guide them through the process, which is crucial. I know that the culture imbued by Sir Robert Francis is an enabling one about helping victims, particularly with evidence. I have also signed off both legal support and financial support, because it is about receiving what are, in many cases, life-changing sums of money.

• 13 Feb 2025 · Infected Blood Compensation Scheme · Hansard source

  More

  I can certainly give that assurance both to my hon. Friend and to his constituent, Sue. The Government will continue to push this forward as quickly as is reasonably possible. I am conscious of the strength of feeling, and I am also conscious that victims have waited decades for justice, and that need for speed is recognised across Government.

• 6 Feb 2025 · UK-EU Relations · Hansard source

  More

  I thank the shadow Chancellor of the Duchy of Lancaster for his contribution. Of course NATO remains the cornerstone of our security; that has been a cross-party position for decades. He asks about plans and red lines. I refer him to our manifesto, which was put to the people last year, that contains those clear red lines of no return to freedom of movement, the single market or the customs union. He can see in that examples of what the Government are seeking to negotiate. The hon. Gentleman talks about negotiating international agreements. There are many people from whom I would take advice about international agreements, but I hope the House will forgive me if the Conservatives—the party that managed to send hundreds of millions of pounds to Rwanda and all they got in return was sending some volunteers and most of their Home Secretaries there—are not at the front of the queue for giving advice on how to negotiate international agreements. I give some credit to the Leader of the Opposition, who strikes a markedly different tone on this issue from that struck by the hon. Gentleman today. She admits freely that the last Government left without a plan for growth, and that, frankly, they ended up making it up as they went along. I was surprised that the hon. Gentleman did not begin his remarks by repeating that apology. Perhaps he has a different view than the one taken by his leader. The hon. Gentleman talks about the jurisdiction of the European Court of Justice, but he was part of a Government who negotiated a role for the European Court of Justice in the Windsor framework. He talks about standards. This Government are committed to the highest standards, whether that is on product safety, employment rights or consumer rights. We believe in a race to the top on standards, not the race to the bottom that would be the dream of the Conservatives. As the Government move forward, our test is the national interest. It is about making Britain safer, more secure and more prosperous. There is another test for the Leader of the Opposition, however. I see that she has put out a social media video about tests, which is worth a couple of minutes for mild entertainment if nothing else. The test for her is whether she will face down the ideologues in her party. Is she going to show some political courage and back the national interest, or is she just going to back down in the face of the ideologues in her party? On the basis of the hon. Gentleman’s contribution, I am not optimistic.

• 6 Feb 2025 · UK-EU Relations · Hansard source

  More

  My hon. Friend raises an important point. I am pleased that we have already increased our National Crime Agency presence at Europol. The speed with which we can share data is hugely important. When crimes are committed, those early hours and days are so important for catching those responsible. We want to work with the EU and international partners so that criminals have no place to hide on our continent.

• 23 Jan 2025 · Relations with the EU · Hansard source

  More

  I am astonished by the question, because the hon. Gentleman is also the shadow Northern Ireland Secretary, and will know the role that the European Court of Justice plays in the Windsor framework. Turning to his question about the negotiations, we have set out our red lines in the manifesto, and have set out examples of things that we are seeking to negotiate—that is already there. The Leader of the Opposition was apologising last week for the conduct of the Conservative party in its relationship with the EU. Why is the hon. Gentleman not starting with an apology, or did he just not get the memo from his leader?

• 23 Jan 2025 · Infected Blood Compensation Scheme: Payments · Hansard source

  More

  The whole House will be moved by the story of my hon. Friend’s constituent. It is a story from this appalling scandal that many of us across the House will be hearing from our constituents. I am pleased that first payments have been made to people who have waited far too long for compensation. Those payments were made by the end of 2024, as I committed to the House to do. I also commit specifically to my hon. Friend to working closely with the devolved Administrations to ensure that victims across the United Kingdom can achieve justice.

• 24 Oct 2024 · Topical Questions · Hansard source

  More

  I thank my hon. Friend for that question; she is a long-standing champion for justice for victims of the infected blood scandal and, indeed, the nuclear test veterans that she mentioned. We are looking to introduce a broad duty of candour—a general duty of candour. I should also point out that criminal sanctions will be really important to punish the most egregious breaches, and I am pleased to confirm today, as the Prime Minister announced in September, that the Bill we will bring forward will include criminal sanctions.

• 23 Oct 2024 · Infected Blood Compensation Scheme · Hansard source

  More

  I beg to move, That the Infected Blood Compensation Scheme Regulations 2024 (SI, 2024, No. 872), dated 22 August 2024, a copy of which was laid before this House on 23 August, be approved. Let us start by reminding ourselves why we are here today. The infected blood scandal is a mark of shame on the British state. The infected blood inquiry’s final report, which was published on 20 May, shed light on the trauma inflicted on thousands of people across the country through no fault of their own. People were given contaminated blood or blood products and contracted HIV, hepatitis C and hepatitis B, and then for years they had their voices ignored. Those who were affected—the people who loved, knew and cared for someone who was infected—similarly had their voices ignored. That did nothing but compound the trauma for all involved. The infected blood inquiry’s second interim report, published in 2023, set out 18 recommendations on compensation, informed by Sir Robert Francis KC’s 2022 compensation scheme study. The inquiry was unequivocal that a compensation scheme must be set up immediately. The regulations before the House are essential for delivering that compensation scheme and getting money to people as quickly as we can. In May, when the now Prime Minister and I responded to Sir Brian Langstaff’s inquiry, we were absolutely clear. I said: “One of the most powerful conclusions in this report is that an apology is meaningful only if it is accompanied by action”. —[ Official Report , 21 May 2024; Vol. 750, c. 748.] Today, with the regulations and the compensation scheme, we are delivering that action and taking another step on the road to the justice that has been so cruelly delayed.

• 23 Oct 2024 · Infected Blood Compensation Scheme · Hansard source

  More

  As the right hon. Member for Salisbury (John Glen) and I have indicated, Sir Robert Francis engaged extensively around the country during the general election. The point the hon. Lady makes about continuously trying to make what is a complex scheme open and transparent is entirely fair and I share the desire to do that. My hon. Friend the Member for Blyth and Ashington (Ian Lavery) has constantly been a powerful voice for victims of the infected blood scandal. I have indicated in previous remarks that we will engage with the charities and groups on what more support we can give to them. On the 20 cases, that is about a test-and-learn approach to try to be able to ramp up the scheme and make it operate more quickly. On the unethical research—an appalling and dreadful practice—the Government have accepted the amount of money that was suggested, but it should be emphasised always that these are not payments in isolation; they are just a part, and in the vast majority of cases will be a small proportion, of the amounts of money that will be paid out. The right hon. Member for Rayleigh and Wickford (Mr Francois) spoke powerfully, and I echo his words about the former right hon. Member for Horsham, with whom I had a number of conversations about this matter. I know that he was concerned and wanted to drive the matter forward. The right hon. Member for Rayleigh and Wickford spoke powerfully about the two cases in his constituency and the need for closure, which is a hugely powerful emotion. My hon. Friend the Member for Bournemouth West (Jessica Toale) spoke powerfully about Jane Fitzgerald. She also spoke about Ronan Fitzgerald, who I understand is in the Gallery today and who is continuing the extraordinary fight for justice in which he has been engaged for so long. My hon. Friend asked a series of questions. If she writes to me with each of them, I will ensure that she receives a response. The hon. Member for Sutton and Cheam (Luke Taylor), who is back on the Liberal Democrat Benches, raised the issue of siblings, which I addressed a moment or two ago. He is entirely right to highlight the importance of communications and transparency. My hon. Friend the Member for Eltham and Chislehurst (Clive Efford) steps into giant shoes as the chair-designate of the APPG, because my right hon. Friend the Member for Kingston upon Hull North and Cottingham (Dame Diana Johnson) did an extraordinary job in taking this matter forward. He talked about different Government Departments. The Cabinet Office has led on this issue because of the history of the Department of Health in the 1970s and 1980s. That is why I and the previous Paymaster General took on this responsibility. My hon. Friend is right to emphasise that we should continue to engage with the infected blood community; that is a discussion I frequently have with the chair of the Infected Blood Compensation Authority, who I know shares my hon. Friend’s desire to do so. The hon. Member for Perth and Kinross-shire (Pete Wishart) asked me about legal support, and we have accepted that it should be provided. He talked about my powers in that regard, which have been exercised. That legal support will happen, and it is hugely important that it does. We want the tariff scheme to be as quick and accessible as possible, and we want people to have that level of support. My hon. Friend the Member for Normanton and Hemsworth (Jon Trickett) spoke powerfully of people’s scepticism about state institutions. The introduction of a duty of candour is hugely important with regard to not only this scandal, but others such as Horizon and Hillsborough. His point about document destruction was very well made, but one of the reasons for using a tariff-based scheme, rather than having thousands of individual court cases, is precisely that the documents that are available can be treated more sensitively and on the basis of the balance of probabilities. The hon. Member for Mid Sussex (Alison Bennett) spoke extraordinarily movingly about her constituent Graham Knight, his wife Sue and the support that she provided. It was a privilege to listen to a fantastic maiden speech by my hon. Friend the Member for Leeds North West (Katie White), who is the first female Member of Parliament for her constituency. She spoke with great Yorkshire pride and about her constituents understandably feeling let down in the past. She certainly did not let them down today with her maiden speech, which was positive about the way that politics can deliver real change. I am sure it is the start of a very fine parliamentary career. Her grandmother, Marjorie Simms, would have been extraordinarily proud of her today. The hon. Member for South Devon (Caroline Voaden) spoke about her constituent Philip, who summed up one chilling aspect of this scandal when he said, “our ignorance was engineered by those in power.” It is worth reflecting on that sentence as we look at the changes that we will need to make, beyond ensuring that people receive compensation. My hon. Friend the Member for Glasgow South (Gordon McKee) spoke powerfully about his constituent, Roberta, and the stigma that she suffered. He also spoke about the Murray family, and if he writes to me about their specific circumstances, I will ensure that he gets a response. The hon. Member for Stratford-on-Avon (Manuela Perteghella) spoke movingly about family members and carers, and I agree with her about their huge importance. My hon. Friend the Member for Welwyn Hatfield (Andrew Lewin) spoke about the Blake family. I think that caseworkers will be hugely important in the work of the Infected Blood Compensation Authority. I note that, understandably, the first constituent the hon. Member for St Neots and Mid Cambridgeshire (Ian Sollom) mentioned did not even want her name to be mentioned. That is an indication of the ongoing pervasive nature of this scandal. My hon. Friend the Member for Cramlington and Killingworth (Emma Foody) spoke for all of us when she said it had taken far too long to reach justice. She is welcome to write to me about the point she raised. I think she was talking about legal fees that have already been incurred, but if she writes to me I will ensure that she gets a response.

• 23 Oct 2024 · Infected Blood Compensation Scheme · Hansard source

  More

  My hon. Friend makes a powerful point about trust in the process. The scheme is designed to have a core route, and a supplemental route for particular issues around care claims or financial loss that are not appropriately captured in the core route. There is also provision around review and appeals to the first-tier tribunal, which is important. One of the purposes of having a tariff-based scheme is to try to make it simpler and easier to access, so that the need for subsequent appeals is minimised. I know that the House speaks as one when it comes to paying long overdue compensation to those impacted by this harrowing scandal. Following the passing of the Victims and Prisoners Act, these regulations are the next substantial step towards getting money to people who rightly deserve it. However, although there has been progress, the work is far from finished. A second set of regulations will provide for other elements of the compensation scheme, including compensation payments to those who are affected and for claims outside the core route. Subject to parliamentary approval, the Government aim for the second set of regulations to be in place by 31 March 2025, to support our intention—as I have previously told this House—for those affected to start receiving payments next year. There is shared determination across the House to deliver compensation as swiftly as possible and with the minimum delay. I hope that today, hon. Members across the House can agree that these regulations are a significant step towards that.

• 23 Oct 2024 · Infected Blood Compensation Scheme · Hansard source

  More

  Yes, the awards are exempt from inheritance tax and capital gains tax. That is precisely how the scheme has been designed. I hope that gives reassurance to the hon. Gentleman. Let me move on to the points raised by the Secondary Legislation Scrutiny Committee, as it is important that I address them. As the Committee noted, the infected blood scandal stretches back over many decades, and access to records, in particular medical evidence, will be very challenging—I acknowledge that. That is at the very heart, as I am sure hon. and right hon. Members will understand, of the challenge of trying to address an injustice that has been allowed to continue for so many decades. Where that is the case, the authority will need to make objective decisions relying on the evidence that is available in order to determine, on the balance of probabilities, that treatment with infected blood occurred. The authority will—I expect it to do this—provide assistance to those who believe that their medical records have been lost or destroyed, and evidencing eligibility will be easier, faster and more compassionate than, for example, one would experience through any court proceedings. The Committee highlighted the complexity of the regulations. That is why, alongside the publication of the regulations and the explanatory memorandum, the Government published a detailed policy paper in August on how the compensation scheme will operate, setting out what individuals can expect to receive, including case study examples. Additionally, the Infected Blood Compensation Authority will ensure that appropriate advice and support is available to assist people with managing their compensation awards, accessing financial services and accessing benefits advice where relevant, as I set out in response to an earlier intervention by my hon. Friend the Member for Hartlepool (Mr Brash). Thirdly, the Committee raised questions on how claimants will receive payments. As set out in recommendation 10 of the infected blood inquiry’s second interim report, the regulations include a mechanism for electing for periodic compensation payments or a lump sum. That is responding to the wishes of those who have told us that they wanted that option to be available to them. We have also provided an alternative for those currently receiving support scheme payments through the infected blood support schemes. The so-called IBSS route was developed following the recommendations of Sir Robert Francis KC, following his engagement with representatives of the infected blood community. The clearest finding from that engagement was around the continuation of the existing support scheme payments. The Government have listened, and we have agreed and accepted that support scheme payments will continue for life for those who elect the IBSS route. The route will be available for those who applied to be registered on a support scheme on or before 31 March 2025, and delivered as part of the compensation package. The tariff-based scheme is designed to be fast, fair, consistent and secure. We hope that people will be satisfied that they have been provided with full and fair compensation, as the scheme sets out. However, should that not be the case, the regulations make provision for review of decisions made by the authority and for appeals to the first-tier tribunal.

• 23 Oct 2024 · Infected Blood Compensation Scheme · Hansard source

  More

  If I understand the hon. Gentleman’s intervention correctly, he is talking about the different organisations that already exist. We will consider all the recommendations in the round, but he is absolutely right to highlight the hugely important role of those organisations. The Infected Blood Compensation Authority will look to work with the different support organisations. That is vital. The scheme is based on the recommendations and principles put forward by the inquiry. In line with those, and supported by advice from the inquiry response expert group, it was updated following the engagement exercise that Sir Robert Francis KC undertook in June with victims and representatives of the infected blood community. The Government have sought to design a fair and comprehensive compensation scheme, which will also be quick and simple for eligible applicants to access. I turn first to eligibility. The scheme and the regulations define people who are eligible as infected people, in line with recommendation 2 of the inquiry’s second interim report. That covers people infected with HIV, hepatitis C and hepatitis B, and it includes people directly infected by treatment with blood as well as people indirectly infected via transmission from a directly infected person. Secondly, the regulations establish a core route for claiming compensation as an infected person. The core route provides for compensation to be awarded under five categories or heads of loss, as set out in recommendation 6 of the inquiry’s report: an injury impact award, a social impact award, a care award, a financial loss award and an autonomy award. Together, they will comprise the total compensation award to infected individuals, or to the estate of any deceased infected individuals, to recognise the wide-ranging harm resulting from their infection. Earlier this year, the Victims and Prisoners Act 2024 established the Infected Blood Compensation Authority in law to deliver the scheme. I am proud to have campaigned with many Members across the House to have delivered that change in legislation; I pay tribute to the right hon. Member for Salisbury (John Glen) for his role. I am proud that this Government are now delivering on that commitment. The regulations before the House will provide the Infected Blood Compensation Authority with the legal powers that it needs to begin making payments. They also provide further detail on how it will accept applications and pay awards. The authority, under the chairmanship of Sir Robert Francis, has been working hard to design and implement effective, simple and secure processes that put the infected blood community at the heart of its work. Last week, the Infected Blood Compensation Authority reached out to the very first claimants under the scheme. The authority is taking a test-and-learn approach that will ensure that it can take feedback on board and improve the service before it opens its full compensation service. I hope that that step provides confidence that we are absolutely committed to driving forward progress to meet our shared intention of beginning payments by the end of this year, as I have previously said to the House. I will do everything in my power to ensure that all those who are entitled to compensation receive it as soon as possible.

• 23 Oct 2024 · Infected Blood Compensation Scheme · Hansard source

  More

  I note that time is short. I will get through as many of the points that have been raised as I can, but I say to all right hon. and hon. Members that my door is very much open; please do follow up with a letter to me if there are specific points that you want me to provide a more detailed response to. I would be more than happy to do that. In this debate we should always start with the victims at the forefront of our minds—what they went through, and how long, unfairly, they had to fight for justice. Several Members have raised the excellent work that support groups do, in supporting victims and providing advocacy for them. The Government will be engaging with those groups. The Government will be asking what more support is required. Several Members asked about that; the Government will take that work forward. I will try to move through the points on the basis of the order in which they were raised, starting with the right hon. Member for Salisbury (John Glen). He can certainly take my assurance that the Government are in rapid delivery mode. The point he made about complexity is a fair one. In addition to the explanatory memorandum there was an explainer, and there were case studies, published on gov.uk. I know, too, that the IBCA will provide direct support to each individual who applies for compensation. There will be caseworkers to seek to ensure that individuals understand how the scheme works and the choices they can make. Work is under way on the second set of regulations. In drafting the new explanatory memorandum I will take on board the point that was made by the Committee, and by the right hon. Member for Salisbury, and use plain and simple English wherever possible. I have set out a number of times in the House that payments will be beginning by the end of 2024. A number of Members asked about the initial 20. The reason for that is that the IBCA is adopting a test-and-learn approach. Taking an initial representative group is the best way subsequently to ramp up the process to be as swift as possible. That has been done with the objective of getting money out of the door as quickly as possible. Of course it will now be for the IBCA to build a service that balances speed with ease of use—and of course data security, which I know would be another concern for the House. On the second set of regulations about the supplemental route in respect of the infected and the affected, I am saying not that they will be laid by 31 March 2025 but that, subject to the vote of this House, I want them to have passed through the House by that date. I want us to move as swiftly as we possibly can. The decision on the sequencing—the split between the infected and the affected that the Government have adopted in these regulations—was made on the basis that it would allow orderly implementation of the legal framework without impacting or delaying the delivery timetable for payments to the infected and the affected. As I have said, I hope for, and am sure that I will have, the House’s assistance in ensuring that the regulations can be approved by 31 March next year. I may have misunderstood the point made by the right hon. Member for Salisbury about an impact assessment, but the equality impact assessment is on the Government website. As for the question of cost, he has not long to wait now; he will be able to study the Budget Red Book next week. My hon. Friend the Member for Newport East (Jessica Morden) has been an extraordinarily powerful advocate for the Smith family. I do not think any of us can ever imagine the pain of losing a child in those circumstances. I hope that she heard my reassurance about the work of charities, and the work that the Government will now do to engage with the groups. I have been asked a number of times about our next action, which involves the interim payments for the estates of the deceased infected. I promise that the deadline of the end of October will be met, and I will update the House tomorrow during Cabinet Office questions. I have also been asked about further opportunities to debate this issue. I have already promised that there will be a debate this year about progress on the implementation of Sir Brian Langstaff’s 12 recommendations. Compensation is obviously one of them, and I am sure that the House will understand why I am trying to drive that forward as quickly as I can, but the others are hugely important as well, and will be debated in the House.

• 23 Oct 2024 · Infected Blood Compensation Scheme · Hansard source

  More

  I would be only too delighted to engage with the all-party parliamentary group, and I am sure that if my hon. Friend sends an invitation in the usual way, we can find a mutually convenient date. My hon. Friend has just referred to the all-party group, and the spirit in which this debate has been conducted is really important. It is crucial that that cross-party approach continues. We are dealing with people who have been failed by the state, and we must acknowledge that. The regulations we are debating ensure that we can finally deliver compensation to those who have fought so hard and waited so long for justice in the most harrowing of circumstances. They deserve nothing less, and I hope that colleagues across the House will join me in supporting the regulations. I commend them to the House. Question put and agreed to . Resolved, That the Infected Blood Compensation Scheme Regulations 2024 (SI, 2024, No. 872), dated 22 August 2024, a copy of which was laid before this House on 23 August, be approved.

• 2 Sept 2024 · Infected Blood Compensation Scheme · Hansard source

  More

  Thank you, Madam Deputy Speaker; I think this is the first time that I have spoken with you in the Chair, so I congratulate you on your election. I am grateful for the opportunity to update the House on the Government’s work on the infected blood compensation scheme, following my letter to Mr Speaker during the recess. The infected blood scandal is a shameful mark on the British state, and those who have been impacted have waited far too long to receive financial redress and true recognition of their suffering. The inquiry’s report shed light on the trauma inflicted on thousands of people across the country. The voices of people who are infected and have been affected have gone unheard for far too long, which has compounded the trauma. The devastating findings of the report bear repeating: victims were used as objects of unethical research, and people were misled about the treatments they needed and received. As Sir Brian Langstaff KC put it, there was a “cover-up” that was “more subtle, more pervasive and more chilling” than an “orchestrated conspiracy to mislead”. It is a shameful part of our state’s recent history. On 26 July, I updated this House on the engagement exercise being undertaken by Sir Robert Francis KC, interim chair of the new Infected Blood Compensation Authority, with the infected blood community on the compensation proposals that were published on 21 May. As I told the House, the Government were carefully considering Sir Robert’s feedback with a view to publishing his report and the Government’s position on it in advance of 24 August, which was the statutory deadline imposed by the Victims and Prisoners Act 2024 for establishing the infected blood compensation scheme in regulations. I assure the House that this Government upheld that commitment, and I thank all the officials who worked in the Cabinet Office to ensure that that deadline was met. On 16 August, the Government published on gov.uk an update on the infected blood compensation scheme, Sir Robert Francis’s report on his engagement exercise, and the infected blood inquiry response expert group’s final report. I met with some representatives of the community and with Health Ministers from the devolved Administrations, and I made calls to parliamentarians on both sides of the House so that they were informed of the Government’s progress prior to publication. I have come to the House today to provide the Government’s update on next steps, but I would like to acknowledge the work and the valued contributions of Sir Robert Francis and the expert group appointed by the right hon. Member for Salisbury (John Glen) at the start of the year. It is the Government’s intention to deliver a comprehensive compensation scheme at the earliest possible opportunity, in order to provide justice and closure to the infected blood community, which has historically been neglected and mistreated. I put on record my thanks to Sir Robert Francis. Through both his compensation framework study in 2022—which was taken into account in the inquiry—and his recent engagement exercise in June with key representatives of the community, he has contributed greatly to the development of the infected blood compensation scheme. He listened to the concerns of the community, and his most recent report took on board both those concerns and other feedback from a diverse group of representatives. Sir Robert made 74 recommendations to the Government, covering a wide range of areas, including the future of the current infected blood compensation schemes, additional supplementary awards for those who were subjected to unethical medical research, and amendments to the five key heads of loss that inform the total compensation package for victims. The Government accepted the vast majority of those recommendations: 69 of the 74 were accepted. For the five that the Government have not accepted, it is because we believe that a different solution will be more practical and better for the victims. The Government heard the infected blood community’s concerns about the 21 May proposal to phase out the regular infected blood support scheme payments upon delivery of compensation payments. I know that that proposal was causing great anxiety to those in receipt of, and reliant upon, those payments. The Government have listened, and we have changed the compensation proposal accordingly. Regular support scheme payments for those registered before 1 April 2025 will continue for life as part of the compensation package. Support scheme payments are not the only thing to change. In the next set of regulations we will enhance the total compensation package to introduce a supplementary additional autonomy award of £10,000 for those who were subject to unethical medical research, as a specific acknowledgement of the impact on their personal freedom. That award will be uplifted to £15,000 for those who were subjected to research at Treloar’s college as children, as recommended by Sir Robert. I want to make it clear to the House that those payments will be on top of the comprehensive compensation package currently set out in the regulations that a person will receive. Another of the community’s concerns about the 21 May proposal was the social impact award for affected individuals. Again, following feedback, we are increasing that award for individuals who are assumed to have lived in the same household as an infected person for two years or more. The scheme has been designed in line with the principles of the inquiry, having regard for “speed of provision, simplicity of process, accessibility, involvement, proactive support, fairness and efficiency.” We recognise that this means that the scheme will not cover every circumstance in the way an individual assessment would, so in order to ensure that every applicant is justly compensated, we have introduced a health impact supplementary route for additional compensation. Sir Robert produced a wide-ranging report following the engagement exercise and some of his recommendations relate specifically to the delivery of the scheme. Although it is for the Government to deliver the design of the scheme and to ensure that the legal framework to deliver it is in place via new regulations—and we remain committed to doing that—it is of course the case that the Infected Blood Compensation Authority will be administering the scheme. We welcome the recommendations and we are confident that the authority, of which Sir Robert is the interim chair, will work tirelessly to operationalise and implement the compensation scheme as soon as possible, so that money can be passed to victims at the earliest opportunity. I would also like to thank the infected blood inquiry response expert group, which has informed the Government’s development of the infected blood compensation scheme. As Sir Robert recommended, we have published the expert group’s final report, which provides more detail on the rationale for decisions taken on the scheme design. The expert group report includes detailed descriptions of each of the heads of loss that make up the total compensation package, the clinical markers used to determine severity bandings, and the formulae for the care award and financial loss award. As I have referenced, the Victims and Prisoners Act 2024 required the Government to establish the infected blood compensation scheme by 24 August. I am pleased to confirm to the House that on 23 August we laid the regulations that will give the Infected Blood Compensation Authority the powers necessary to pay compensation through the core route to the infected, both living and deceased. This will allow individuals who were infected with HIV, hepatitis C or hepatitis B through the use of contaminated blood or blood products to receive the compensation they so wholly deserve. Personal representatives of those who have tragically passed away as a result of their infection will be able to apply for compensation on behalf of their loved ones. The Government are clear that although laying the regulations relating to infected individuals taking the core route is an essential step to delivering justice, the work is not finished. A second set of regulations will provide for other elements of the compensation scheme, including compensation payments to affected individuals and for claims under the supplementary route. We are committed to delivering this second set of regulations when parliamentary time allows, to ensure that those applying under these routes can start receiving payments in 2025. The Government’s plans regarding that second set of regulations are in the documents available on gov.uk. It is an important step to have the compensation scheme enshrined in law, but I know that many people will want to know exactly when they can expect to receive their compensation. The Infected Blood Compensation Authority will deliver the compensation scheme and I know the interim chief executive and his team are working hard to put the operational systems in place with the aim of beginning payments by the end of this year. That will involve user testing with members of the community who have volunteered to help the authority to ensure that it is designed to address the specific needs of applicants. Those who are registered with the infected blood compensation schemes will have their details shared with the Infected Blood Compensation Authority, to deliver on the promise that the Government will endeavour to make the process as user-friendly and free of distress as possible. Beneficiaries of the infected blood compensation schemes will be contacted in due course regarding the sharing of their data with the Infected Blood Compensation Authority. I am grateful for the opportunity to update the House today on this important work. The victims of the infected blood scandal have waited far too long for justice, and I am encouraged that we are now beginning to deliver this long-awaited compensation. I undertake to continue to update the House as this work progresses. I commend this statement to the House.

• 2 Sept 2024 · Infected Blood Compensation Scheme · Hansard source

  More

  I am grateful to my hon. Friend. The report sets out the five different areas of loss: those from injury and the social impact, then the autonomy award for the real effect on people’s freedom and family life, and also the loss from the care people have received, and financial loss as well. Those are the major heads of loss under the scheme and it is important to reflect the very different ways in which people were affected. It is also important to accept, as Sir Brian Langstaff set out, that a tariff-based scheme is crucial as well. That is to try to make this process as simple as the Government possibly can and to ensure people receive the justice they deserve.